Skip to Content
Merck

YSC1

Yeast from Saccharomyces cerevisiae

Type I

Synonym(s):

(Bakers yeast)

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

NACRES:
NA.81
UNSPSC Code:
12352202
Form:
powder or solid
Biological source:
Saccharomyces cerevisiae
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


biological source

Saccharomyces cerevisiae

Quality Level

type

Type I

form

powder or solid

application(s)

food and beverages
microbiology

storage temp.

2-8°C

General description

Yeast from Saccharomyces cerevisiae (Baker′s yeast) is the oldest microbial starter. It is a facultative anaerobe.

Application

Yeast from Saccharomyces cerevisiae has been used:
  • as a biocatalyst for the anode of yeast microbial fuel cell
  • for the production of ethanol for fuel use
  • to prepare yeast extract

Biochem/physiol Actions

Yeast from Saccharomyces cerevisiae (Baker′s yeast) is used as a protein supplement, energy booster and immune enhancer. It serves as a dough leavening agent in bread production by converting the fermentable sugars to CO2 and ethanol. Baker′s yeast exhibits aroma, anti-molding and nutritive properties. It acts as a cell factory.

Preparation Note

Dried to avoid inactivation of enzymes.

Disclaimer

Autolyzes in aqueous buffer at 37 °C.


Still not finding the right product?


Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Engineering baker?s yeast: room for improvement
Randez-Gil F, et al.
Trends in biotechnology, 17(6), 237-244 (1999)
Zachariah P G Olufs et al.
Scientific reports, 8(1), 2348-2348 (2018-02-07)
Genetic variability affects the response to numerous xenobiotics but its role in the clinically-observed irregular responses to general anesthetics remains uncertain. To investigate the pharmacogenetics of volatile general anesthetics (VGAs), we developed a Serial Anesthesia Array apparatus to expose multiple
Electrostatically enhanced performance of a yeast-based microbial fuel cell
Song Y, et al.
Royal Society of Chemistry Advances, 5(25), 19203-19205 (2015)



Global Trade Item Number

SKUGTIN
YSC1-500G04061837588198
YSC1-100G04061837588174
YSC1-1KG04061837588181